Related references
Note: Only part of the references are listed.Research data as a global public good
J. Andre Knottnerus
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics
J. Jaime Caro
PHARMACOECONOMICS (2016)
Psst, Have I Got a Model for You ...
J. Jaime Caro
MEDICAL DECISION MAKING (2015)
Decision-Analytic Models: Current Methodological Challenges
J. Jaime Caro et al.
PHARMACOECONOMICS (2014)
Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report
J. Jaime Caro et al.
VALUE IN HEALTH (2014)
Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States
Kit N. Simpson et al.
PHARMACOECONOMICS (2013)
Modeling Using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
Jonathan Karnon et al.
MEDICAL DECISION MAKING (2012)
Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
J. Jaime Caro et al.
MEDICAL DECISION MAKING (2012)
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
David M. Eddy et al.
MEDICAL DECISION MAKING (2012)
Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
Mark Roberts et al.
MEDICAL DECISION MAKING (2012)
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Uwe Siebert et al.
VALUE IN HEALTH (2012)
A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data
James G. Xenakis et al.
PHARMACOECONOMICS (2011)
No Head-to-Head Trial? Simulate the Missing Arms
J. Jaime Caro et al.
PHARMACOECONOMICS (2010)
DISCRETE EVENT SIMULATION OF CARDIAC HOSPITALS PERFORMING PERCUTANEOUS CORONARY INTERVENTIONS
P. Pei et al.
VALUE IN HEALTH (2010)
Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?
Jaime J. Caro et al.
VALUE IN HEALTH (2010)
Restrictive usage of monoclonal immunoglobulin λ light chain germline in POEMS syndrome
Daijiro Abe et al.
BLOOD (2008)
Invasive meningococcal disease epidemiology and control measures:: a framework for evaluation
J. Jaime Caro et al.
BMC PUBLIC HEALTH (2007)
Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone
J. Jaime Caro et al.
VALUE IN HEALTH (2007)
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
PM Clarke et al.
DIABETOLOGIA (2004)
Estimating survival for cost-effectiveness analyses: A case study in atherothrombosis
JJ Caro et al.
VALUE IN HEALTH (2004)
Share Paper
